Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease

Journal of Neuroscience

Volumn 18, Issue 5, 1998, Pages 1806-1817

  Nakao, Naoyuki ^a   Ogura, Mitsuhiro ^a   Nakai, Kunio ^a   Itakura, Toru ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Basal ganglia; c Fos; Cytochrome oxidase; Dopamine neurons; Neural transplantation; Parkinson's disease

Indexed keywords

APOMORPHINE; CYTOCHROME C OXIDASE; DOPAMINE; PROTEIN C FOS;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DOPAMINE RELEASE; GENE EXPRESSION REGULATION; MALE; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

EID: 0032031586     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-05-01806.1998     Document Type: Article

References (64)

1. Abercrombie M (1946) Estimation of nuclear population from microtome section. Anat Rec 94:239-247.
2. Afsharpour S (1985) Topographical projections of the cerebral cortex to the subthalamic nucleus. J Comp Neurol 236:14-28.
3. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
4. Berger B, Thierry AM, Tassin JP, Moyne MA (1976) Dopaminergic innervation of the rat prefrontal cortex: a fluorescence histochemical study. Brain Res 106:133-145.
5. Björklund A (1992) Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr Opin Neurobiol 2:683-689.
6. Blunt AB, Jenner P, Marsden CD (1992) Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-DOPA and carbidopa. Brain Res 582:299-311.
7. Bouthenet M-L, Martres P, Salés N, Schwanz J-C (1987) A detailed mapping of dopamine D2 receptors in rat central nervous system by autoradiography with [ 125I]iodosulpride. Neuroscience 20:117-155.
8. Brown LL, Makman MH, Wolfson LI, Dvorkin B, Warner C, Katzman R (1979) A direct role of dopamine in the rat subthalamic nucleus and intrapeduncular area. Science 206:1416-1418.
9. Brundin P, Duan W-M, Sauer H (1994) Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum. In: Functional neural transplantation (Dunnett SB. Björklund A, eds), pp 157-195. New York: Raven.
10. Burbaud P, Gross C, Benazzouz A, Coussemacq M (1995) Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons. Exp Brain Res 105:48-58.
11. Campbell GA, Eckardt MJ, Weight FF (1985) Dopaminergic mechanisms on subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis. Brain Res 333:261-270.
12. Canteras NS, Shammah-Lagnado SJ, Silva BA, Ricardo JA (1988) Somatosensory inputs to the subthalamic nucleus of rat: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res 458:53-64.
13. Centi MA, Campbell K, Mandel RJ, Wictorin K, Björklund A (1992) Dopaminergic transplants normalize amphetamine- and apomorphineinduced Fos expression in the 6-hydroxydopamine lesioned striatum. Neuroscience 46:943-957.
14. Centi MA, Campbell K, Björklund A (1993) Neuropeptide-mRNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin-, preprotachykinin- and prodynorphin-mRNA levels. Neuroscience 57:275-296.
15. Chesselet M-F, Delfs JM (1996) Basal ganglia and movement disorders: an update. Trends Neurosci 19:417-422.
16. Dawson TM, Dawson VL, Gage FH, Fisher L, Hunt MA, Wamsley JK (1991) Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra. Exp Neurol 111:282-292.
17. DeLong MR (1990) Primates models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
18. Dragunow M, Robertson HA (1987) Kindling stimulation induces c-fos protein in granule cells of the rat dentate gyrus. Nature 329:441.
19. Freed WJ, Ko GN, Niehoff DL, Kuhar MJ, Hoffer BJ, Olson L (1983) Normalization of spiroperidol binding in the denervated rat striatum by homologous grafts of substantia nigra. Science 222:937-939.
20. Fremeau RT, Duncam GE, Fornaretto M-G, Dearry A, Gingrich JA, Breese GR, Caron MG (1991) Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc: Natl Acad Sci USA 88:3772-3776.
21. Gagnon C, Bédard PJ, Rioux L, Gaudin D, Martinoli MG, Pelletier G, DiPaolo T (1991) Regional changes of striatal dopamine receptors following denervation of by 6-hydroxydopamine and fetal mesencephalic grafts in the rat. Brain Res 558:251-263.
22. Gaspar P, Bloch B, Lemoine C (1995) D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur J Neurosci 7:1050-1063.
23. Hassani O-K, Mouroux M, Féger J (1996) Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience 72:105-115.
24. Hefti F, Melamed E, Sahakian BJ, Wurtman RJ (1980) Circling behaviour in rats with partial, unilateral nigrostriatal lesions, effect of amphetamine, apomorphine, and DOPA. Pharmacol Biochem Behav 12:185-188.
25. Herrero M-T, Levy R, Ruber M, Luquin MR, Villares J, Guillen J, Faucheux B, Javoy-Agid F, Guridi J, Agid Y, Obeso JA, Hirsch EC (1996) Consequence of nigrostriatal denervation and L-DOPA therapy on the expression of glutamic acid decarboxylase (GAD) messenger RNA in the pallidum. Neurology 47:219-224.
26. Hevner RF, Liu S, Won-Riley MTT (1995) A metabolic map of cytochrome oxidase in the rat brain: histochemical, densitometric and biochemical studies. Neuroscience 65:313-342.
27. Hollerman JR, Grace AA (1992) Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol. Brain Res 590:291-299.
28. Hudson JL, Bickford P, Johansson M, Hoffer BJ, Strömberg I (1994) Target and neurotransmitter specificity of fetal central nervous system transplants: importance of functional reinnervation. J Neurosci 14:283-290.
29. Kageyama GH, Wong-Riley MTT (1982) Histochemical localization of cytochrome oxidase in the hippocampus: correlation with specific neuronal types and afferent pathways. Neuroscience 7:2337-2361.
30. Kincaid AE, Albin RL, Newman SW, Penney JB, Young AB (1992) 6-Hydroxydopamine lesions of the nigrostriatal pathway alter expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons. Neuroscicnce 51:705-718.
31. Kitai ST, Kita H (1987) Anatomy and physiology of the subthalamic nucleus: a driving force of the basal ganglia. In: The basal ganglia II, structure and function - current concepts (Carpenter MB, Jayaraman A, eds), pp 357-373. New York: Plenum.
32. 14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement. Brain Res 197:167-183.
33. Kreiss DS, Anderson LA, Walters JR (1996) Apomorphine and dopamine D1 receptor agonists increase the firing rates of subthalamic nucleus neurons. Neuroscience 72:863-876.
34. Law-Tho D, Hirsch JC, Crepel F (1994) Dopaminergic modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study. Neurosci Res 21:151-160.
35. Levy R, Hazarati L-N, Herrero M-T, Vila M, Hassani O-K, Mouroux M, Ruberg M, Asensi H, Agid Y, Féger J, Obeseo JA, Parent A, Hirsch EC (1997) Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscicnce 76:335-343.
36. Lindvall O (1994) Neural transplantation in Parkinson's disease In: Functional neural transplantation (Dunnett SB, Björklund A, eds). pp 103-107. New York: Raven.
37. Meibach MRC, Katzman R (1979) Catecholaminergic innervation of the subthalamic nucleus: evidence for a rostral continuation of A9 (substantia nigra) dopaminergic group. Brain Res 173:364-368.
38. Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs DE, Sambrook MA, Crossman AR (1989) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine. Neuroscience 32:551-554.
39. Nakao N, Frodl EM, Duan W-M, Widner H, Brundin P (1994) Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci USA 91:12408-12412.
40. Olanow CW, Kordower JH, Freeman TB (1996) Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19:102-108.
41. Palombo E, Porrino LJ, Bankiewicz KS, Crane AM, Sokoloff L, Kopin IJ (1990) Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP. J Neurosci 10:860-869.
42. Pan HS, Walters JR (1988) Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat. Synapse 2:650-656.
43. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. San Diego: Academic.
44. Porrino LJ, Burns RS, Crane AM, Palombo E, Kopin IJ, Sokoloff L (1987) Local cerebral metabolic effects of L-DOPA therapy in 1-methyl-4-phenyI-1,2,3,6-tetrahydropyridinc-induced parkinsonism in monkey. Proc Natl Acad Sci USA 84:5995-5999.
45. Porter RHP, Greene JG, Higgins Jr DS, Greenamyre JT (1994) Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J Neurosci 14:7192-7199.
46. Rajakumar N, Rushlow W, Rajakumar B, Naus CCG, Stoessel AJ, Flumerfelt BA (1997) Effects of graft-derived dopaminergic innervation on the target neurons of patch and matrix compartments of the striatum. Neuroscience 76:1173-1185.
47. Rioux L, Gaudin DF, Gagnon C, Di Faolo T, Bédard PJ (1991) Decrease of behavioral and biochemical supersensitivity of rat striatum by nigral transplants. Neuroscience 44:75-83.
48. Robertson HA, Peterson MR, Murphy K, Robertson GS (1989) D1dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res 503:346-349.
49. Robledo P, Féger J (1990) Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res 518:47-54.
50. Sagar SM, Sharp FR, Curran T (1988) Expression of c-Fos protein in brain: metabolic mapping at the cellular level. Science 240:1328-1331.
51. 3H]SCH 23390. Brain Res 375:291-301.
52. 2 receptor densities caused by 6-hydroxydopamine lesions of the nigrostriatal pathway in rats. An autoradiographic study. Neuroscience 46:729-728.
53. Schwartzman RJ, Alexander GM, Ferraro TN, Grothusen JR (1988) Cerebral metabolism of parkinsonian primates 21 days after MPTP. Exp Neurol 102:307-313.
54. Segovia J, Garcia-Munoz M (1987) Changes in the activity of GAD in the basal ganglia of the rat after striatal dopaminergic denervation. Neuropsychopharmacology 26:1449-1451.
55. Sirinathsinghji DJS, Dunnett SB (1991) Increased proenkephalin mRNA levels in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP +): reversal by embryonic nigral dopamine grafts. Mol Brain Res 9:263-269.
56. Soghomonian JJ, Chesselet MF (1992) Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse 11:124-133.
57. Soghomonian JJ, Pednault S, Audet G, Parent A (1994) Increased glutamate decarboxylase mRNA level in the striatum and pallidum of MPTP-treated primates. J Neurosci 14:6256-6265.
58. Strömberg I, Johanson S, Hoffer B, Olson L (1985) Leinnervation of dopamine-denervated striatum by substantia nigra transplants: immunohistochemical and electrophysiological correlates. Neuroscience 14:981-990.
59. Vila M, Levy R, Herrero M-T, Faucheux B, Obeso JA, Agid Y, Hirsch EC (1996a) Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry. Neuroscience 71:903-912.
60. Vila M, Herrero M-T, Levy R, Faucheux B, Ruberg M, Guillen J, Luquin MR, Guridi J, Javot-Agid F, Agid Y, Obeso JA, Hirsch EC (1996b) Consequences of nigrostriatal denervation on the GABAergic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology 46:802-809.
61. Vila M, Levy R, Herrero M-T, Ruberg M, Faucheux B, Obeso JA, Agid Y, Hirsch EC (1997) Consequences of nigrostriatal denervation on the function of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 17:903-912.
62. Wong-Riley MMT (1979) Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res 171:11-28.
63. Wong-Riley MMT (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12:94-101.
64. Wooten GF, Collins RC (1981) Metabolic effects of unilateral lesion of the substantia nigra. J Neurosci 1:285-291.